GWRE News Alert Guidewire Software Inc. Common (GWRE) 51.54 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board

Dec 25, 2014 at 7:46 PM

Guidewire Software Inc. Common (GWRE) 51.54 $GWRE

Insider Trading Alert - GWRE, CLSN And ADI Traded By Insiders
at The Street - Tue Dec 23, 1:30PM CST
Stocks with insider trader activity include GWRE, CLSN and ADI
CLSN: 2.39 (+0.06), GWRE: 51.54 (+0.28), ADI: 56.71 (+0.05)

Why You Shouldn't Bet Against Guidewire Software (GWRE) Stock - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 19, 8:06AM CST
Guidewire Software is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective.
GWRE: 51.54 (+0.28)

Guidewire and Sollers Consulting Host Third Annual "Innovations in Insurance" Conference with a Focus on General Insurance Industry Transformation
Business Wire - Tue Dec 16, 3:05PM CST
Sollers Consulting, a specialist in consulting and implementation services for the insurance industry, and Guidewire Software (NYSE: GWRE), a provider of software products to Property/Casualty (General) insurers, co-hosted the third annual international Innovations in Insurance conference earlier this month in Warsaw, Poland. The theme of this year's conference was business transformation and featured presentations from leading British and Polish insurers including Aviva UK, AXA, Beazley, PZU, and Zurich UK, discussing industry issues such as non-standard distribution channels and the role of Big Data.
GWRE: 51.54 (+0.28)

Capital Insurance Group Selects Guidewire System for Underwriting and Policy Administration
Business Wire - Mon Dec 15, 7:55AM CST
Capital Insurance Group (CIG), a leading Property/Casualty (P/C) insurer serving the Western United States, and Guidewire Software, Inc. (NYSE:GWRE), a provider of software products to P/C insurers, today announced that CIG has selected Guidewire PolicyCenter(R) as its new underwriting and policy administration solution. CIG has also selected Guidewire Rating Management(TM) and Guidewire Client Data Management(TM). Guidewire PartnerConnect(TM) Consulting partner, PwC US, has been selected to lead the implementation project.
GWRE: 51.54 (+0.28)

Insider Trading Alert - BRC, GWRE And GLAD Traded By Insiders
at The Street - Fri Dec 12, 12:30PM CST
Stocks with insider trader activity include BRC, GWRE and GLAD
GWRE: 51.54 (+0.28), GLAD: 8.55 (+0.05), BRC: 27.30 (+0.06)

Germania Insurance Selects Guidewire Products for Underwriting, Policy Administration, Claims Management, Data Management, Business Intelligence, and Billing
Business Wire - Mon Dec 08, 7:55AM CST
Germania Insurance, a Texas Property/Casualty (P/C) insurer, and Guidewire Software, Inc. (NYSE:GWRE), a provider of software products to P/C insurers, today announced that Germania Insurance has selected Guidewire InsuranceSuite(TM) as its new platform for the management of underwriting, policy administration, claims, billing, rating, client data, and reinsurance. The company has also selected Guidewire InfoCenter and DataHub as its data management and business intelligence solutions.
GWRE: 51.54 (+0.28)

Company News for December 04, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 9:10AM CST
Companies in the News are: GIII,LDOS,BOBE,GWRE
GWRE: 51.54 (+0.28), GIII: 99.53 (+1.82), BOBE: 50.58 (-0.04), LDOS: 44.41 (+0.10)

Weak On High Volume: Guidewire Software (GWRE)
at The Street - Wed Dec 03, 9:11AM CST
Trade-Ideas LLC identified Guidewire Software (GWRE) as a weak on high relative volume candidate
GWRE: 51.54 (+0.28)

Guidewire Software's (GWRE) CEO Marcus Ryu on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Dec 02, 7:10PM CST

GWRE: 51.54 (+0.28)

GUIDEWIRE SOFTWARE
at Investor's Business Daily - Tue Dec 02, 5:59PM CST
GUIDEWIRE SOFTWARE (GWRE), a Web-insurance software maker, had 8-cent Q1 EPS vs. a 1-cent loss a year ago, beating. Revenue grew about 20% to $79.73 mil vs. views for $75.98 mil. Shares rose 3.7% to 52.25.
GWRE: 51.54 (+0.28)

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 02, 4:37PM CST

GWRE: 51.54 (+0.28), BV: 7.92 (-0.04), GASL: 4.67 (-0.22), MPLX: 66.22 (+0.55), UVXY: 20.41 (-0.41), OVTI: 26.47 (+0.02), GOL: 5.16 (-0.04), DNR: 8.15 (-0.18), REI: 10.95 (+0.22), PBYI: 189.96 (+0.12)

Guidewire +3.7% AH on FQ1 beat, EPS guidance
Seeking Alpha - at Seeking Alpha - Tue Dec 02, 4:09PM CST

GWRE: 51.54 (+0.28)

Guidewire Software (GWRE) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Dec 02, 3:55PM CST

GWRE: 51.54 (+0.28)

Guidewire Software (GWRE) Stock Climbing in After-Hours Trading After Earnings Beat
at The Street - Tue Dec 02, 3:55PM CST
Guidewire Software (GWRE) shares are up after the company beat analysts' first quarter earnings and revenue expectations.
GWRE: 51.54 (+0.28)

Guidewire Software reports 1Q loss
Automated Insights - Tue Dec 02, 3:15PM CST
FOSTER CITY, Calif. (AP) _ Guidewire Software Inc. (GWRE) on Tuesday reported a fiscal first-quarter loss of $3 million.
GWRE: 51.54 (+0.28)

Guidewire Software beats by $0.05, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Dec 02, 3:07PM CST

GWRE: 51.54 (+0.28)

Guidewire Software Announces First Quarter Fiscal 2015 Financial Results
Business Wire - Tue Dec 02, 3:05PM CST
Guidewire Software, Inc. (NYSE: GWRE), a provider of software products for property and casualty insurers, today announced its financial results for the fiscal quarter ended October 31, 2014.
GWRE: 51.54 (+0.28)

5 Earnings Short-Squeeze Plays: Aeropostale and More
at The Street - Tue Dec 02, 7:43AM CST
Short-sell gains become so outsized in such a short time frame that your profits add up quickly.
GWRE: 51.54 (+0.28), BOBE: 50.58 (-0.04), BKS: 23.46 (+0.38), SHLD: 32.56 (-0.37), ARO: 2.30 (-0.03)

Notable earnings after Tuesday's close
Seeking Alpha - at Seeking Alpha - Mon Dec 01, 4:35PM CST

GWRE: 51.54 (+0.28), BV: 7.92 (-0.04), OVTI: 26.47 (+0.02), BOBE: 50.58 (-0.04), ASNA: 12.25 (+0.02)

Insider Trading Alert - MACK, GWRE And CCOI Traded By Insiders
at The Street - Wed Nov 19, 11:34AM CST
Stocks with insider trader activity include MACK, GWRE and CCOI
MACK: 10.91 (+0.36), GWRE: 51.54 (+0.28), CCOI: 34.97 (-0.06)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SVRN Taps Industry Vet Patrick O'Kain as COO

SVRN Aims for New Heights with a Savvy Hire If there’s one thing veteran market-watchers like myself know, it’s that leadership shifts can tell you more about a company’s guts than any press release. SVRN (NASDAQ: SVRN), a name with one foot firmly in the world of digital assets, just snagged Patrick O’Kain for their COO spot. They're not playing around, folks,...

Survey Reveals 'TDS' Impact on 2026 Midterm Elections

Midterms and 'Trump Derangement Syndrome': What's the Deal? Every election season there's something new to raise eyebrows, and this time it's 'Trump Derangement Syndrome' (TDS) taking the spotlight. After the dust of the 2026 mid-terms started settling, it turns out there's more than just traditional candidate bickering shaping votes. Can you guess what's driving voters?...

Sempra Shines with Robust Q3 2026 Financials

Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....

Coastal Financial Faces Class Action Suit Over Securities

Securities Law Tangles: Coastal Financial Hits a Snag There's no dodging it—Coastal Financial Corporation's dogged by a class action lawsuit, and investors need to sit up and take notice. This kind of legal fracas can hit the stock price like a brick through a window, especially when alleged securities law violations crop up. DJS Law Group's got the reins on this one,...

Grant Davis Joins Assembly Health as CXO

By Olivia Taylor Updated Nov 4, 2026 Category News Views 101

Shuffling Pieces in Healthcare Management Change is constant in healthcare management, folks, and it's all about finding the right puzzle pieces. That's what Assembly Health has done by welcoming Grant Davis as their new Chief Experience Officer (CXO). Yeah, you heard me right. It's not a CEO or a CFO, but the CXO role that's under the spotlight this time around, aiming...

MAURE's Three-Year Mark: Crafting Home Elegance

Brooklyn's Gem: MAURE Turns Three Over in Brooklyn, there's a brand bubbling with style called MAURE. Now, we're talking three years strong, surviving the wild bout of the retail scene with a firm two feet planted in home and gifting. The Vision Turned Reality When Maureen Cavalieri, a hospitality veteran since 2009, first tossed this spark into the wind in 2023, it...

Dizal Unveils Promising Data at ASH 2026

Pushing the Horizons in Hematological Research From the bustling streets of Shanghai to the global stage of the ASH 2026, Dizal has made its mark again. This year's presentations could very well shake up the hematological landscape, showcasing new possibilities for treatment strategies. Golidocitinib: A Game-Changer? Now here's a ticket we've been watching with some high...

LOA Roofing's Growth Recap Taps Southstone's Backing

Pardon my skepticism, but when a roofing company names itself Life of Abundance, you know they're aiming to hit it big or at least make you think they're onto something special. LOA Roofing and Construction, holding its ground as a major player in the Central Texas market, set the stage for more ambitious growth. And they found themselves a dance partner in Southstone...

SKF's Industrial Push: Energy Efficiency at COP31

SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...

Eli Lilly's Retatrutide Trials Signal Innovation

Unpacking Lilly's Latest Rheumatology Innovations Lilly's taking the stage at ACR Convergence 2026 with a potent arsenal of data that’s got folks buzzing. The company’s put the pedal to the metal on understanding the intertwining chords of obesity and rheumatologic conditions, and boy, are they not messing around. Retatrutide: A Triple Threat in the Making Headlining...